Antimicrobial Stewardship: Optimization of Antibiotic Practices

Internet Enduring Material Sponsored by the Stanford University School of Medicine. Presented by the Division of Infectious Diseases in the Department of Medicine at the Stanford University School of Medicine

Antibiotics are among the most frequently prescribed classes of drugs and it is estimated that approximately 50% of antibiotic use, in both the outpatient and inpatient settings, is inappropriate. At the same time, in contrast to any other class of drugs, every antibiotic use has a potential public health consequence – inappropriate use may not harm only the individual patient, but contributes to societal harm by exerting an unnecessary selective pressure that may lead to antibiotic resistance among bacteria.

This course will offer a number of illustrative cases, recognizable to the practicing physician in his or her practice to engage the learners in the thought processes that lead to optimal decision making, improved outcomes of individual patients, and harm reduction vis-a-vis the bacterial ecology.

This course will offer a practical approach to prescribing antibiotic therapy and development of antimicrobial stewardship to physicians and pharmacists across all specialties and settings.

• Release Date: November 21, 2013
• Expiration Date: November 22, 2015
• Estimated Time to Complete:  6 hours
• CME Credits Offered: 6.00
• Registration Fee: $20.00 USD

• Review the information below, then click the Join for Free button to register and access the course material. If you have already registered for this activity, click the Go to Course button.
  
  • View all of the videos, then follow the link at the end of the last video to register for CME and pay the $20 CME Processing Fee.
    
  • Complete the CME course evaluation, CME post-assessment and CME post-test.
  • 75% of case-based post-test questions must be answered correctly in order to receive a CME certificate that will be emailed to the address provided within 2 weeks from the date of receipt.
    
  • Learners will have 3 attempts to pass the post-test.
    
  • The Stanford University School of Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    
• *Participation in discussion forums, chat rooms, homework assignments and additional readings are not certified for AMA PRA Category 1 Credit™.

• Develop skills to apply IDSA guidelines in treating common infections such as acute rhino-sinusitis.
  
• Apply evidence based antibiotic management to treat sepsis.
  
• Implement principles of antimicrobial stewardship when providing care to special populations and in various settings.
  
• Apply evidence based antibiotic management to surgical patients requiring antibiotic prophylaxis.
  
• Apply evidence based antibiotic stewardship program in the outpatient setting.

Unit 1: The Basic Clinical Science of Antimicrobial Use
Unit 2: Practical Aspects of Antimicrobial Stewardship and Application to Special Circumstances and Populations

• The following Course Director has indicated that he has a relationship with industry to disclose relative to the content of this activity during the planning phase. This relationship no longer exists and as a faculty member he has nothing to disclose:
  • Stan Deresinski, MD FIDSA
    Clinical Professor, Medicine
    Infectious Disease
    Antimicrobial Stewardship Program Medical Director
    Stanford University
    
    Pfizer: Advisory Board member
• The following speakers have indicated that they have a relationship with industry to disclose relative to the content of this activity:
  • Thomas File, Jr MD MACP FIDSA FCCP
    Professor of Internal Medicine
    Head ID Section
    Northeastern Ohio Universities Colleges of Medicine and Pharmacy
    Rootstown, Ohio
    Chief, Infectious Disease Service
    Summa Health System Akron, Ohio
    
    Astellas Pharma, Cubust, Durata, GSK, Merck: Advisory Board member Pfizer, Boehringer Ingelheim, Gilead, Tobotec: Research 
    Bayer AG, DalishSankyo, Forest: Consulting
  • 
    Jason Newland, MD
    Medical Director, Patient Safety and System Reliability; Associate Professor of Pediatrics,
    University of Missouri-Kansas City School of Medicine
    Children’s Mercy Hospital Kansas City
    
    Pfizer: Research

The following planners, speakers and authors have indicated that they have no relationships with industry to disclose relative to the content of this activity: 

• Mike McAuliffe
  Stanford EdTech 
• Pauline Becker
  Stanford EdTech 
• Relly Brandman
  Coursera

You will need a reasonably reliable Internet connection to access course resources and to watch (or download) lecture videos. Please note that while most features of the Coursera site will load and function on a mobile device (such as a smartphone or a tablet), Coursera does not officially support these devices and cannot guarantee full site functionality if you are accessing Coursera from a mobile device. More information available via Coursera’s help page.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Stanford University School of Medicine designates this enduring material for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology. A portion of this funding supports this activity.

California Assembly Bill 1195 requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. It is the intent of the bill, which went into effect July 1, 2006, to encourage physicians and surgeons, CME providers in the State of California and the Accreditation Council for Continuing Medical Education to meet the cultural and linguistic concerns of a diverse patient population through appropriate professional development. The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area. The Stanford University School of Medicine Multicultural Health Portal also contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.

You are encouraged to visit the portal: http://lane.stanford.edu/portals/cultural.html

Click here to review the Stanford Center for CME Privacy Policy

If you are having technical problems (video freezes or is unplayable, can't print your certificate, etc.) you can submit a Help Request to the OpenEdX Team. If you have questions related to CME credit, requirements (Pre-test, Post-test, Evaluation, Attestation) or course content, you can contact the CME Online support team at cmeonline@stanford.edu